Inspire Medical Plunges On Outlook Cut, Weak V System Rollout: Analysts React
1. INSP stock plunged after Q2 earnings reports and lowered guidance. 2. Revenue increased 11% year-over-year, exceeding expectations. 3. The company reported a loss of 12 cents per share this quarter. 4. Commercial launch of Inspire V system faces delays, impacting revenue. 5. Analysts downgraded INSP stock and lowered price targets significantly.